Press releases from pharmaceutical companies or Seattle Children's or University of Washington

Single-Dose Malaria Vaccine Achieves 90% Protection in New Study Published in Nature Medicine by Seattle Children's and University of Washington

Jan 3, 2025, 03:16 PM

A recent study published in 'Nature Medicine' has revealed a breakthrough in malaria vaccination, demonstrating that a single-dose immunization using a genetically weakened whole malaria parasite vaccine can provide 90% protection against the disease. This development is part of ongoing research efforts to combat malaria, with the study being led by scientists from Seattle Children's and the University of Washington. Additionally, NIH researchers have identified a novel class of antibodies that targets a previously untapped portion of the malaria parasite, which could pave the way for new prevention strategies. These findings highlight significant advancements in malaria vaccine research and potential new avenues for treatment.